Table of Contents
<< Previous Issue | Oct 2009 (Vol: 2009, Issue: 10) | Next Issue >> |
- Section: Cartoons
-
Cool Hats
- Section: Editorial
-
Still Waiting for the Turning Point in Deal Making
- Section: Joint Venture
-
GSK forms Joint Venture to Tap China’s Vaccine Market
- Section: Licensing
-
AstraZeneca Inks Deal with Nektar
-
LEO Re-acquires Dermatology Drug Rights from Warner Chilcott
-
Novartis Deals Add New Antibiotic and Discovery Programme
-
GSK Opens Rare Diseases Portfolio with Prosensa’s DMD Candidate
- Section: Mergers & Acquisitions
-
Abbott Sees Emerging Markets Growth with Solvay Buyout
-
Sanofi Continues its Buying Spree
-
Onyx Acquires Proteolix
- Section: Research & Development
-
J&J Diversifies into Vaccines
-
Theraclone’s Influenza Antibody Alliance With Japanese Co
-
GSK Signs Cancer Deal with SuperGen